Teucrium Soybean Fund (SOYB) Financials
Newest figures come from the 10-Q for Q1 FY2026, filed May 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SOYB SEC filings page.
This page shows Teucrium Soybean Fund (SOYB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Reported losses have narrowed, but the asset base contracted and operating cash flow stayed negative in FY2022-FY2024, pointing to a smaller financial footprint.
Cash conversion broadly tracked reported earnings across the available periods. In FY2021, operating cash flow of$75.2M nearly matched$82.4M of net income; by FY2024, operating cash flow of-$39.4M was also close to the$47.9M net loss, suggesting results were not dominated by a persistent accounting-only gap.
Reported net loss narrowed from
Total assets fell from
Financial Health Signals
We do not publish a peer-relative financial health score for Teucrium Soybean Fund, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Teucrium Soybean Fund reported $30.4M in net income in Q1 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Not reported for Q1 2026.
Not reported for Q1 2026.
Not reported for Q1 2026.
Cash & Balance Sheet
Teucrium Soybean Fund held $641.4M in cash as of Q1 2026; no long-term debt figure is on record for that period.
Not reported for Q1 2026.
Not reported for Q1 2026.
Margins & Returns
None of these metrics is reported for Q1 2026.
Capital Allocation
None of these metrics is reported for Q1 2026.
SOYB Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $2.0M | N/A | N/A | $11.1M | N/A |
| SG&A Expenses | N/A | N/A | N/A | $71K+34.2% | $78K-36.8% | $71K+44.2% | $55K | $53K+12.9% |
| Net Income | $30.4Mn/m | -$3.1Mn/m | N/A | -$56Kn/m | -$10.9Mn/m | -$23.5Mn/m | $8.8M | -$29.0M-416.0% |
| EPS (Basic) | N/A | N/A | N/A | N/A | N/A | $1.05-45.6% | N/A | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, EPS (Diluted), Diluted Shares (Avg).
SOYB Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | N/A | N/A | $241.7M-25.9% | $257.4M-30.2% | $268.0M-26.5% | $296.7M-24.4% | $326.0M-35.5% | $369.0M |
| Cash & Equivalents | $641.4M+235.6% | $191.2M-24.7% | $210.9M-27.8% | $233.3M-27.7% | $228.1M-26.7% | $253.7M-23.2% | $292.2M-32.7% | $322.5M |
| Total Liabilities | N/A | N/A | $17.0M+49.4% | $10.2M-62.8% | $27.0M-40.6% | $18.9M-46.5% | $11.4M-71.6% | $27.4M |
| Total Equity | N/A | N/A | $224.6M-28.6% | $247.2M-27.6% | $241.0M-24.5% | $277.8M-22.2% | $314.5M-32.4% | $341.6M |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt, Retained Earnings.
SOYB Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | -$1.6Mn/m | $199Kn/m | -$25.5Mn/m | $5.6M | -$38.3Mn/m |
| Financing Cash Flow | N/A | N/A | N/A | $6.9M-86.2% | -$25.8Mn/m | -$13.1Mn/m | -$35.9M | $49.8Mn/m |
| Share Buybacks | N/A | N/A | N/A | $25.3M-34.2% | $47.8M-19.5% | $26.9M-75.8% | $56.4M | $38.4M-83.8% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid.
SOYB Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Net Margin | N/A | N/A | N/A | -2.8% | N/A | N/A | 79.3% | N/A |
| Return on Equity | N/A | N/A | N/A | 0.0%+8.5pp | -4.5%+2.6pp | -8.5%+0.1pp | 2.8% | -8.5% |
| Return on Assets | N/A | N/A | N/A | 0.0%+7.8pp | -4.1%+2.2pp | -7.9%-0.2pp | 2.7% | -7.9% |
| Liabilities-to-Equity | N/A | N/A | 0.080.0x | 0.040.0x | 0.110.0x | 0.070.0x | 0.040.0x | 0.08 |
| Asset Turnover | N/A | N/A | N/A | 0.01+0.1x | -0.030.0x | -0.070.0x | 0.03 | -0.07 |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, Debt-to-Equity, FCF Margin.
Where Teucrium Soybean Fund Ranks
Frequently Asked Questions
No, Teucrium Soybean Fund (SOYB) reported a net loss of $26.5M in fiscal year 2025.